Professor Tim Spector and his Zoe co-founder Jonathan Wolf have issued advice for those looking to change their diets in the ...

Zoe co-founder Tim Spector warned that a prime opportunity is going to waste even for those using weight loss jabs ...

Comparing Tyrzepatide and Semaglutide in the slimming drug market, with potential growth driven by increasing obesity rates ...

Ozempic was originally approved to treat people with Type 2 diabetes, but demand has surged because of the drug’s weight-loss ...

Xeno Biosciences may have been unable to prove that its drug delivering oxygen to the gastrointestinal tract can induce ...

This Summerville couple topped 360 pounds each but have since lost more than 350 pounds combined. It took lifestyle changes, ...

Genetics contribute between 40% and 70% of what determines a person’s weight, and the rest is environmental factors like diet, exercise, medications, stress, sleep patterns and overall ...

A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts ...

Hershey (NYSE: HSY) isn't normally viewed as a high-yield stock, but its dividend yield of 3.2% today is near its highest ...

Food manufacturers are trying to whip themselves up a forkful of the slimming trend — but nutrition experts aren’t giving them a good review.

Nina King says that Ozempic's rise could shift beauty standards away from thinness as it becomes more accessible.

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 489.81% and ...